527 related articles for article (PubMed ID: 1719535)
1. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon.
Popik W; Pitha PM
Virology; 1992 Aug; 189(2):435-47. PubMed ID: 1641975
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.
Vlach J; Pitha PM
J Virol; 1993 Jul; 67(7):4427-31. PubMed ID: 8389940
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes.
Margolis DM; Rabson AB; Straus SE; Ostrove JM
Virology; 1992 Feb; 186(2):788-91. PubMed ID: 1310199
[TBL] [Abstract][Full Text] [Related]
6. A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein.
Chapman CJ; Harris JD; Collins MK; Latchman DS
AIDS; 1991 Aug; 5(8):945-50. PubMed ID: 1777175
[TBL] [Abstract][Full Text] [Related]
7. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
10. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
11. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
[TBL] [Abstract][Full Text] [Related]
12. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
Swingler S; Easton A; Morris A
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
[TBL] [Abstract][Full Text] [Related]
13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
15. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
Su Y; Popik W; Pitha PM
J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
18. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
Roebuck KA; Gu DS; Kagnoff MF
AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
20. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
Popik W; Pitha PM
J Virol; 1994 Mar; 68(3):1324-33. PubMed ID: 8107197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
